JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:631-642, doi:10.1016/j.jacc.2006.09.046 (Published online 25 January 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, C.
Right arrow Articles by Bourassa, M. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Berry, C.
Right arrow Articles by Bourassa, M. G.

Coronary Heart Disease in Patients With Diabetes

Part I: Recent Advances in Prevention and Noninvasive Management

Colin Berry, MD, PhD2, Jean-Claude Tardif, MD, FACC1 and Martial G. Bourassa, MD, FACC*

Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.


Figure 1
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Cumulative Incidence of Diabetes According to Study Group

The incidence of diabetes differed significantly among the 3 groups (p < 0.001). Compared with placebo, the lifestyle intervention reduced the incidence of diabetes during follow-up by 58% (95% confidence interval [CI] 48% to 66%) and metformin reduced it by 31% (95% CI 17% to 43%). The incidence of diabetes was 39% lower (95% CI 24% to 51%) in the former than in the latter group. Reproduced from The Diabetes Prevention Program Research Group (66) with permission.

 

Figure 2
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Cumulative Incidence of Cardiovascular Outcomes

Cumulative incidence of the first of any of the predefined cardiovascular disease (CVD) outcomes (A) and of the first occurrence of nonfatal MI, stroke, or death from CVD (B). Compared with conventional treatment, intensive diabetic treatment reduced the risk of any predefined CVD outcome by 42% (95% confidence interval [CI] 9% to 63%; p = 0.02) (A) and reduced the risk of the first occurrence of nonfatal MI, stroke, or death from CVD by 57% (95% CI 12% to 79%; p = 0.02) (B). Reproduced from Nathan et al. (28) with permission.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.